Raks Pharma is an API manufacturer based in India. It holds 72 active US drug master files. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 29 August 2025 as NAI. Customs aggregates show $3.4M of exports covering 19 molecules to 3 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Anakapalli, India | 3008250894 |
| Dahej, India | Not on file |
| dahejbharuc h 392 130, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Abiraterone | SFDA (Saudi Arabia), US FDA | 2 |
| Azathioprine | US FDA | 2 |
| Dexlansoprazole | US FDA | 2 |
| Doxycycline | US FDA | 2 |
| Esomeprazole | US FDA | 2 |
| Metyrosine | SFDA (Saudi Arabia), US FDA | 2 |
| Omeprazole | US FDA | 2 |
| Prochlorperazine | US FDA | 2 |
| Tramadol | US FDA | 2 |
| Apremilast | US FDA | 1 |
| Atazanavir | US FDA | 1 |
| Atorvastatin | US FDA | 1 |
| Bosentan | US FDA | 1 |
| Brexpiprazole | US FDA | 1 |
| Calcium | US FDA | 1 |
| Carvedilol | US FDA | 1 |
| Celecoxib | US FDA | 1 |
| Chlordiazepoxide | US FDA | 1 |
| Chlorpromazine | US FDA | 1 |
| Citalopram | US FDA | 1 |
| Clidinium | US FDA | 1 |
| Clobazam | US FDA | 1 |
| Clopidogrel | US FDA | 1 |
| Colestipol | US FDA | 1 |
| Dapagliflozin | US FDA | 1 |
| Darunavir | US FDA | 1 |
| Doxepin | US FDA | 1 |
| Dronedarone | US FDA | 1 |
| Eliglustat | US FDA | 1 |
| Eltrombopag | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | None | 2 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $296K | 1 |
| 2025 | Not reported | $3.4M | 3 |
| 2024 | Not reported | $3.7M | 4 |
| 2023 | Not reported | $3.8M | 5 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Raks Pharma comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.